Synopsys Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively increased by 3.0% to $1.92M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $1.55M to $1.92M. Over 5 years (FY 2020 to FY 2025), Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively shows an upward trend with a 4.0% CAGR.
An increase often reflects the issuance of shares for employee compensation or capital raises, while a decrease reflects share buybacks.
This represents the aggregate par value of all issued and outstanding common shares of the company. It reflects the foun...
This is a standard line item across all public companies, though the par value per share is often nominal and varies by jurisdiction.
equity_common_stock_value| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.53M | $1.53M | $1.53M | $1.53M | $1.53M | $1.52M | $1.52M | $1.52M | $1.52M | $1.52M | $1.53M | $1.53M | $1.54M | $1.54M | $1.55M | $1.55M | $1.86M | $1.86M | $1.92M |
| QoQ Change | — | +0.3% | +0.1% | -0.2% | +0.0% | -0.4% | +0.0% | -0.1% | -0.1% | +0.0% | +0.3% | +0.5% | +0.3% | +0.3% | +0.4% | +0.3% | +19.5% | +0.3% | +3.0% |
| YoY Change | — | — | — | — | +0.3% | -0.5% | -0.6% | -0.5% | -0.6% | -0.2% | +0.1% | +0.6% | +1.0% | +1.3% | +1.4% | +1.3% | +20.8% | +20.7% | +23.8% |